Last update:
Oncology news
AI blood assay detects liver cancer across diverse international populations
Researchers at the Johns Hopkins Kimmel Cancer Center validated an artificial intelligence (AI)-powered blood test that accurately detected liver cancer in people from two geographically and biologically distinct populations ...
13 minutes ago
0
0
ACSS2 protein identified as therapeutic target for metastatic liver tumors
Liver metastases are one of the most common sites of cancer spread, and the survival rates are very low. However, Cancer Center at Illinois (CCIL) researchers recently identified a new promising therapeutic target.
1 hour ago
0
0
Natural tooth count indicates long-term survival following pancreatic cancer surgery
Oral health is known to be linked to overall health, and research has shown relationships with a variety of diseases. Impaired oral health has been linked to prognosis in colorectal cancer and esophageal cancer. Previous ...
1 hour ago
0
0
Scientists identify fructose as a surprise driver of cancer spread
A new study from The Wistar Institute has uncovered an unexpected link between fructose—a common dietary sugar—and the spread of an aggressive form of ovarian cancer. Published in Nature Aging, the study found that cancer ...
19 hours ago
0
329
This amino acid may help the body fight tumors and viral infections
The amino acid arginine helps keep the human body humming, most notably by synthesizing proteins that carry out a range of cellular processes. It's produced by our bodies and found in common high-protein foods. Low levels ...
16 hours ago
0
40
A quantum machine learning framework to predict neoantigen immune response
Cleveland Clinic and IBM researchers are using quantum computing to tackle one of the most challenging problems in immuno-oncology: predicting which tumor mutations will trigger an immune response.
19 hours ago
0
3
Combination therapy improves progression-free survival for patients with metastatic dMMR colorectal cancer
Patients with deficient DNA mismatch repair (dMMR) or microsatellite instability-high (MSI-H) metastatic colorectal cancer experienced a 58% reduction in the risk of disease progression or death when treated with atezolizumab ...
12 hours ago
0
4
Tumor-on-a-chip method reveals timing as a factor in glioblastoma immunotherapy
A joint research team led by professors Sungsu Park of Sungkyunkwan University and Sun-Ha Paek of Seoul National University College of Medicine has demonstrated for the first time that the sequence in which immune cells interact ...
23 hours ago
0
6
Mental distress, fatigue common in childhood survivors of leukemia, lymphoma
Adult childhood cancer survivors (CCS) of acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML) and non-Hodgkin lymphoma (NHL) frequently report mental distress, fatigue and executive function (EF) impairment, ...
14 hours ago
0
4
Tanning is getting hot again. Here's what it really does to your skin
Nichole Sims started using a tanning bed at 15 because she said everyone around her was doing it, especially before events like homecoming dances and prom.
18 hours ago
0
4
Flawed studies linking hormone therapy to breast cancer made doctors reluctant to prescribe it for menopause relief
Although menopause is not a new phenomenon by any means, the past few years of what some have called the "menopause moment" have brought it to the forefront of the national conversation.
22 hours ago
0
8
New research identifies barriers transgender individuals face related to breast cancer risk
Transgender and gender-diverse (TGD) individuals experience significant health care disparities across the oncology spectrum of care. Systemic barriers, past harmful health care experiences, the sociopolitical climate and ...
22 hours ago
0
8
Dual immunotherapy shows promising activity in high-risk early-stage HER2-negative breast cancer
A combination of two immunotherapy drugs showed encouraging activity when added to standard chemotherapy given before surgery for patients with high-risk, early-stage HER2-negative breast cancer, according to Phase II clinical ...
Jul 30, 2026
0
8
Family history raises breast cancer risk even when BRCA testing is negative
Women who test negative for BRCA gene mutations may still be at greater risk of developing breast cancer than the general population, according to a study led by Cedars-Sinai Health Sciences University investigators.
Jul 30, 2026
0
7
Q&A: Are environmental chemicals and endometrial cancer linked?
Researchers at Penn State are investigating whether exposure to endocrine-disrupting chemicals in the environment may play a role in the development of endometrial cancer, particularly among women in rural communities. The ...
Jul 30, 2026
0
4
Targeting tumor acidity pathway may overcome PARP inhibitor resistance in ovarian cancer
Researchers at The University of Texas MD Anderson Cancer Center have discovered a strategy to overcome PARP inhibitor resistance in ovarian cancer, one of the most common barriers to the long-term effectiveness of this widely ...
Jul 30, 2026
0
4
Two post-surgery blood–brain disruption windows may offer glioblastoma treatment targets
Scientists in Britain and Spain have discovered critical windows after glioblastoma surgery when the brain's defenses falter, creating a rare chance to deliver powerful treatments exactly where needed. If doctors time treatment ...
Jul 29, 2026
0
6
Despite Medicare coverage, many cancer patients still do not receive testing that guides treatment options
While there has been a recent increase among Medicare recipients in genomic testing that helps match cancer patients to the most effective treatment for their tumor, many Medicare beneficiaries with cancer are still not receiving ...
Jul 29, 2026
0
4
Donor cord blood composition may influence CAR NK cell therapy outcomes
The composition of donor cord blood may play a critical role in the success of chimeric antigen receptor (CAR) natural killer (NK) cell therapies. A small population of immature NK cells present in donor cord blood can undermine ...
Jul 29, 2026
0
1
Study questions the value of intensive cardiac surveillance in cancer patients treated with anthracyclines
A study led by investigators at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) suggests that intensive cardiac surveillance programs routinely used for lymphoma patients with low to moderate cardiovascular ...
Jul 29, 2026
0
2
Researchers discover pathway that makes glioblastoma cells vulnerable to treatment
New research published in Neuro-Oncology offers a glimpse at promising discoveries that could help shape the future of glioblastoma treatment and patient outcomes.
Jul 29, 2026
0
2
Chemicals present in drinking water may carry a hidden risk tied to uterine cancer
In a recent study, researchers examined whether certain chemicals present in public drinking water are linked to uterine cancer, the most common gynecological cancer in the United States and one that has been steadily increasing ...
Human tissue model tracks glioblastoma invasion cell by cell
Glioblastoma is a malignant brain tumor and is among the most aggressive cancers in humans. Despite multimodal therapy with surgery, radiation and chemotherapy, there is still no cure. A major reason is the tumor's invasive ...
Jul 28, 2026
0
11
Experimental immunotherapy may help patients with high-risk bladder cancer avoid bladder removal surgery
A Mayo Clinic-led international phase 3 study found that a new immunotherapy helped many patients with an aggressive form of bladder cancer keep their bladder instead of having it surgically removed. The treatment also kept ...
Jul 28, 2026
0
115
New study reveals how blood cancers outsmart BTK-targeted therapies
Scientists at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, and collaborators have uncovered a rare genetic mutation that enables some blood cancers to evade both approved ...
Jul 28, 2026
0
10
